{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-058990","form_type":"8-K","ticker":"SRPT","cik":"0000873303","company_name":"Sarepta Therapeutics, Inc.","filed_at":"2023-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.332000+00:00","generated_at":"2026-06-18T13:55:06.167845+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Sarepta exchanges $313.5M of 1.50% convertible notes due 2024 for common stock","bullets":["Approximately $313.5M aggregate principal of 1.50% Convertible Senior Notes due 2024 exchanged for shares of common stock.","Exchange consideration: 12.2589 shares per $1,000 principal plus additional shares based on VWAP formula.","Exchange expected to close on March 7, 2023; shares issued in private placement to accredited investors.","Shares will be freely tradable under Rule 144; no cash paid for accrued interest."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-058990","json":"https://secwatch.observer/filing/0001193125-23-058990.json","markdown":"https://secwatch.observer/filing/0001193125-23-058990.md","text":"https://secwatch.observer/filing/0001193125-23-058990.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/873303/000119312523058990/0001193125-23-058990-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/873303/000119312523058990/d478993d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T13:55:06.167845+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}